Editas Medicine: A Gene Editing Concern To Watch – Seeking Alpha
Seeking Alpha |
Editas Medicine: A Gene Editing Concern To Watch
Seeking Alpha The firm's CRISPR Cpf1 patent portfolio is advancing nicely, with the European Patent Office recently issuing a notice of intent to grant the Broad Institute broad coverage of CRISPR Cpf1 system for human gene editing, which was exclusively licensed to … |
